SYT10: A Potential Drug Target and Biomarker for Neuronal Communication

Target Name: SYT10

NCBI ID: G341359

SYT10

SYT10: A Potential Drug Target and Biomarker for Neuronal Communication

Synaptotagmin X (SYT10), also known as SNX007, is a protein that is expressed in high levels in the central nervous system (CNS) and is involved in the formation of synapses, which are the connections between neurons. The CNS is home to a vast number of neurons that are responsible for various functions, including perception, movement, and thought. Therefore, SYT10 is a protein that plays a critical role in the proper functioning of the CNS.

SYT10 has been shown to be involved in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. Studies have shown that SYT10 is involved in the formation of new synapses, as well as the strengthening and maintenance of existing ones. This is important for the development and maintenance of neural circuits, which are critical for various behaviors and cognitive functions.

In addition to its role in synaptic plasticity, SYT10 has also been shown to play a role in the regulation of neurotransmitter release, which is the release of chemical messengers from neurons that help to communicate with other neurons. Studies have shown that SYT10 is involved in the regulation of the release of dopamine, a neurotransmitter that is involved in pleasure, motivation, and movement.

SYT10 has also been shown to be involved in the regulation of neuroimmune interactions, which are the interactions between the immune system and the brain. Studies have shown that SYT10 is involved in the regulation of the movement of immune cells into the brain, which is important for the immune response to infection and inflammation.

Despite its involvement in so many important biological processes, SYT10 is still an emerging drug target. Studies have shown that SYT10 can be targeted with small molecules, such as those that inhibit its activity or that activate its activity. These small molecules have the potential to be used to treat a wide range of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression.

In addition to its potential as a drug target, SYT10 is also a potential biomarker for certain neurological disorders. The proper functioning of synapses is critical for the development and maintenance of many neurological disorders, including Alzheimer's disease and Parkinson's disease. Therefore, changes in the level of SYT10 expression in the brain can be an important indicator of the severity and progression of these disorders.

SYT10 has also been shown to be involved in the regulation of pain perception, which is an important aspect of neurophysiology. Studies have shown that SYT10 is involved in the regulation of the release of pain-related neurotransmitters, which can help to explain the role of SYT10 in pain management.

In conclusion, SYT10 is a protein that is involved in many important biological processes in the CNS. Its involvement in synaptic plasticity, neurotransmitter release, and neuroimmune interactions makes it an attractive drug target and a potential biomarker for a wide range of neurological and psychiatric disorders. Further research is needed to fully understand the role of SYT10 in these processes and to develop effective treatments for the associated disorders.

Protein Name: Synaptotagmin 10

Functions: Ca(2+) sensor specifically required for the Ca(2+)-dependent exocytosis of secretory vesicles containing IGF1 in neurons of the olfactory bulb. Exocytosis of IGF1 is required for sensory perception of smell. Not involved in Ca(2+)-dependent synaptic vesicle exocytosis (By similarity). Acts through Ca(2+) and phospholipid binding to the C2 domain: Ca(2+) induces binding of the C2-domains to phospholipid membranes and to assembled SNARE-complexes; both actions contribute to triggering exocytosis (By similarity)

The "SYT10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYT10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets